Acadia Phamaceutical presents Nuplazid for Psychosis related to Parkinsons Disease
Posted over 5 years ago by Suzanne Opperman
This announcement has 1 attachment:
Tuesday November 13, 2018, Please RSVP by Friday 11.9.2018
Acadia Pharmaceuticals presents
Jeffrey Boatman, APRN CNS
Nuplazid for the treatment of long term care clients with Psychosis related to Parkinson’s Disease.
6:00 pm Business & Social time
6:30 speaker
Chris McD’s
1600 Forum Blvd, Columbia, Mo
RSVP: Angela Miller
or
314-324-8721. Program #ACA0005506
Comments
No comments yet.
Only active members can comment on this announcement.
Learn more about membership